Join us for a discussion on the new data from TCT 2023 on transcatheter tricuspid valve replacement with the Columbia Structural Heart and Valve team. In this episode, delve into not only the latest findings but also the intriguing questions that arise from the groundbreaking research.

Dive into the latest developments at TCT 2023 as we dissect the low-risk randomized TAVR trials. In this episode, join the conversation with Columbia's Structural Heart and Valve team as they examine updates, share insights, and discuss how the evolving science may reshape our perspectives on TAVR.

Dr. George and the Columbia Valve team discussed new technology from the two largest structural heart companies, the Edwards SAPIEN X4 and the Medtronic Evolut FX.

In this episode, we provide an overview of mitral annular calcification (MAC), with a focus on anatomy, surgical and transcatheter therapy and challenges in treatment.

The Columbia University Valve team discuss the two recent low-risk trials, dissect the results, try to understand how our practices will change, and what to expect in the next 5-10 years.

In Episode two, the Columbia University Heart Valve Team examines the benefits of doing procedures with patients being awake versus asleep.